Anticancer potential of Diospyrin and its analogues: An updated review

Area of Science:

• Natural Product Chemistry
• Pharmacology
• Oncology

Background:

• Cancer's complexity and heterogeneity present global healthcare challenges.
• Existing cancer therapies have associated side effects, necessitating novel approaches.
• Natural products are increasingly explored for developing new cancer treatments.

Purpose of the Study:

• To review the biosynthesis and anticancer activities of Diospyrin and its analogues.
• To discuss the potential mechanisms of action of Diospyrin targeting molecular signal transduction pathways.
• To highlight the toxicological and clinical implications of Diospyrin and its derivatives.

Main Methods:

• Literature review on Diospyrin biosynthesis and anticancer properties.
• Analysis of studies on Diospyrin's molecular targets and signal transduction pathways.
• Examination of toxicological and clinical data for Diospyrin and related compounds.

Main Results:

• Diospyrin, a bis-hydroxy-naphthoquinonoid, exhibits significant bioactivity.
• Diospyrin and its analogues demonstrate promising anticancer activities.
• Potential modes of action involve targeting molecular signal transduction pathways.

Conclusions:

• Diospyrin is a promising lead molecule for developing new chemotherapy agents.
• Further pharmacological and pharmacogenetic studies are essential to elucidate its full anticancer potential.
• Understanding Diospyrin's molecular and genetic mechanisms is crucial for clinical translation.